A Phase I Study of the Heat Shock Protein 90 Inhibitor...

Clinical Cancer Research 2011 / 03 Vol. 17; Iss. 6

A Phase I Study of the Heat Shock Protein 90 Inhibitor Alvespimycin (17-DMAG) Given Intravenously to Patients with Advanced Solid Tumors

Pacey, S., Wilson, R. H., Walton, M., Eatock, M. M., Hardcastle, A., Zetterlund, A., Arkenau, H.-T., Moreno-Farre, J., Banerji, U., Roels, B., Peachey, H., Aherne, W., de Bono, J. S., Raynaud, F., Wor
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-10-1927
Date:
March, 2011
File:
PDF, 831 KB
english, 2011
Conversion to is in progress
Conversion to is failed